Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Patterson....Active COVID and longhaulers are completely different diseases. 2 papers coming about new MOA for CCR5 Antagonists in longhaulers COVID.
Herd immunity in the USA is unlikely: https://www.nytimes.com/2021/05/03/health/covid-herd-immunity-vaccine.html
So, how will FDA answer that problem?
NP may be about to step down. The 22 year Merck guy may end up being a successor.
Great video there! If there are any democrats with influence within the Biden administration or someone like Ed Markey, it would be great if they could see this powerful and succinct presentation of information.
Press coverage in Latin America.
A brief Op-Ed about #Leronlimab published at the Chilean newspaper @elsurcl this week (English translation included). The best evidence available today suggests that this experimental drug may save lives, shorten hospital stays, and release critical beds... pic.twitter.com/jBCfD1sgOV
— Elard Koch, PhD (@ElardKoch) April 24, 2021
Getting noticed in Latin America
An interesting video about #Leronlimab, the powerful anti-CCR5 antibody that can save lives, shorten hospital stays, and release critical beds...https://t.co/HDi5hVk3Yt pic.twitter.com/YfFKHWTskh
— Elard Koch, PhD (@ElardKoch) May 2, 2021
He openly said he had invested in CYDY. What is he lying about then.
As Dr Bream said, FDA approved therapeutic options have to changed in the lat year, who was in charge of therapeutics? https://www.theguardian.com/us-news/2021/jan/28/fda-janet-woodcock-opioids-biden
Janet, I personally had a family member in dire need of a miracle from a terrible bout with COVID. No drugs previous to Leronlimab worked. Even so-called approved drugs. Her suffering was relieved in just 28 hrs after Leronlimab was administered. Why do others need to suffer?
— Brawley Nettles (@BrawleyNettles) May 1, 2021
Later post said it is denied.
He freely disclosed his investment but is not compensated by Cydy or Chiral.
Any idea how long to start clinical trials in Brazil or India? Seems the situation in both places is desperate with the prevalent variants there. Also Oregon is a hot spot with the Brazilian variant, and we havens suspended travel from India until May 4.
https://www.thehindu.com/news/international/coronavirus-us-to-restrict-travel-from-india-over-covid-19-starting-may-4/article34453869.ece
Are these vaiants vaccine resistant? https://www.wsj.com/articles/indian-covid-19-variant-found-in-u-s-across-globe-as-foreign-help-arrives-11619545081
37.9 million shares short according to YMB
It’s quite revealing that the government in the phillipines is more responsive to the needs on its citizens and apparently less corrupt than the United States.
With over 1000 hospitals, the 200,000 vials won’t be enough.
I don’t recall that he did. With Biomm onboard I would expect Brazil would be first.
Nader said trials in Brazil and India
When is Tetra’s trial due?
That is crazy 12 bagger based on a 10 person COVID trial.
Great post!
Thanks Tom!
199.6 thousand more vials to sell. That’s all. It’s like giving a 0.2% discount.
Yep.
Why would Cytodyn so quietly get a clinical portfolio manager with over 20 years at Merck?
Yes, 400 vials free according to statement from Chiral to counter social media speculation about high expense at a million pesos
FDA are working tiressly to protect Americans from Menthol cigarettes while people needlessly die of COVID.
Nice!